UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

International journal of radiation oncology, biology, physics, 2002-08, Vol.53 (5), p.1097-1105

2002

Volltextzugriff (PDF)

A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies

Statistics in medicine, 2019-12, Vol.38 (28), p.5299-5316

2019

Volltextzugriff (PDF)

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer

The Annals of thoracic surgery, 2003-10, Vol.76 (4), p.1001-1008

2003

Volltextzugriff (PDF)

Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions

Carcinogenesis (New York), 2006-10, Vol.27 (10), p.2034-2037

2006

Volltextzugriff (PDF)

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

Journal of thoracic oncology, 2023-10, Vol.18 (10), p.1290-1302

2023

Volltextzugriff (PDF)

Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study

Carcinogenesis (New York), 2014-08, Vol.35 (8), p.1760-1764

2014

Volltextzugriff (PDF)

Landscape of EGFR -dependent and -independent resistance mechanisms to osimertinib and continuation therapy post-progression in EGFR-mutant NSCLC

Clinical cancer research, 2018-09, Vol.24 (24), p.6195-6203

2018

Volltextzugriff (PDF)

MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer

Carcinogenesis (New York), 2010-12, Vol.31 (12), p.2118-2123

2010

Volltextzugriff (PDF)

Abstract 964: Genomic and clinical predictors of early disease progression and chemoimmunotherapy benefit in advanced NSCLC

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.964-964

2023

Volltextzugriff (PDF)

Abstract 4393: Tumor volumetric analysis to correlate disease burden with response to dual immune checkpoint blockade in metastatic NSCLC

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4393-4393

2023

Volltextzugriff (PDF)

Abstract 3685: Analysis of EZH2 and TTF-1 protein expression identifies a subset of lung adenocarcinomas with better prognosis

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3685-3685

2012

Volltextzugriff (PDF)

Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma

Carcinogenesis (New York), 2010-10, Vol.31 (10), p.1755-1761

2010

Volltextzugriff (PDF)

P-1-440 Detection of actionable ALK fusion variants in lung adenocarcinoma

Japanese Journal of Lung Cancer, 2016-11, Vol.56 (6), p.667-667

2016

Volltextzugriff (PDF)

Abstract 955: Specific forms of mutant KRAS predict patient benefit from targeted therapy in the BATTLE-1 clinical trial in advanced non-small cell lung cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.955-955

2011

Volltextzugriff (PDF)

Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid

Surgery, 1998-08, Vol.124 (2), p.203-210

1998

Volltextzugriff (PDF)

Design considerations for efficient prostate cancer chemoprevention trials

Urology (Ridgewood, N.J.), 2001-04, Vol.57 (4), p.205-212

2001

Volltextzugriff (PDF)

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations

Urology (Ridgewood, N.J.), 2001-04, Vol.57 (4), p.4-27

2001

Volltextzugriff (PDF)

Exploring the influence of multiple variables on the relationship of age to quality of life in women WITH BREAST CANCER

Journal of clinical epidemiology, 1992-05, Vol.45 (5), p.473-485

1992

Volltextzugriff (PDF)

Uniform Power Method for Sample Size Calculation in Historical Control Studies with Binary Response

Controlled clinical trials, 2001-08, Vol.22 (4), p.390-400

2001

Volltextzugriff (PDF)

Jaw pain and tenderness levels during and after repeated sustained maximum voluntary protrusion

Pain (Amsterdam), 1991-04, Vol.45 (1), p.17-22

1991

Volltextzugriff (PDF)

40P Evaluation of designs for phase I clinical trials

Controlled clinical trials, 1994-06, Vol.15 (3), p.100-100

1994

Volltextzugriff (PDF)

Electronic thermography of normal facial structures: A pilot study

Oral surgery, oral medicine, oral pathology, 1989-09, Vol.68 (3), p.346-351

1989

Volltextzugriff (PDF)

Allergic Mediator Histamine Confers Immunotherapy Resistance in Cancer Patients via Histamine Receptor 1 on Macrophage

SSRN Electronic Journal

Volltextzugriff (PDF)

Deep Learning CT Signature Predicts Benefit from Immunotherapy in Metastatic NSCLC Independent of Standard Clinicopathological Markers

SSRN Electronic Journal

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Biological And Medical Sciences
(9)
Male
(9)
Medical Sciences
(8)
Middle Aged
(8)
Female
(6)
Oncology
(6)
Adult
(5)
Aged
(5)
Tumors
(4)
Carcinogenesis, Carcinogens And Anticarcinogens
(3)
Models, Statistical
(3)
Neoplasm Staging
(3)
Nephrology. Urinary Tract Diseases
(3)
Otorhinolaryngology. Stomatology
(3)
Pharmacology. Drug Treatments
(3)
Polymorphism, Single Nucleotide
(3)
Reproducibility Of Results
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

A utility‐based Bayesian optimal interval (U‐BOIN) phase I/II design to identify the optimal biological dose for targeted and immune therapies

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer

Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study

Landscape of EGFR -dependent and -independent resistance mechanisms to osimertinib and continuation therapy post-progression in EGFR-mutant NSCLC

MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer

Abstract 964: Genomic and clinical predictors of early disease progression and chemoimmunotherapy benefit in advanced NSCLC

Abstract 4393: Tumor volumetric analysis to correlate disease burden with response to dual immune checkpoint blockade in metastatic NSCLC

Abstract 3685: Analysis of EZH2 and TTF-1 protein expression identifies a subset of lung adenocarcinomas with better prognosis

Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma

P-1-440 Detection of actionable ALK fusion variants in lung adenocarcinoma

Abstract 955: Specific forms of mutant KRAS predict patient benefit from targeted therapy in the BATTLE-1 clinical trial in advanced non-small cell lung cancer

Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid

Design considerations for efficient prostate cancer chemoprevention trials

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations

Exploring the influence of multiple variables on the relationship of age to quality of life in women WITH BREAST CANCER

Uniform Power Method for Sample Size Calculation in Historical Control Studies with Binary Response

Jaw pain and tenderness levels during and after repeated sustained maximum voluntary protrusion

40P Evaluation of designs for phase I clinical trials

Electronic thermography of normal facial structures: A pilot study

Allergic Mediator Histamine Confers Immunotherapy Resistance in Cancer Patients via Histamine Receptor 1 on Macrophage

Deep Learning CT Signature Predicts Benefit from Immunotherapy in Metastatic NSCLC Independent of Standard Clinicopathological Markers

Suchergebnisse filtern